Understanding how fat droplets in brain cells affect Alzheimer's disease
Elucidating roles of microglial lipid droplets in neurodegeneration
This study is looking at how tiny fat droplets in brain immune cells called microglia affect their ability to help keep our brains healthy, especially in people with Alzheimer's disease, and it hopes to find new ways to support these cells to slow down the disease.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11004655 on NIH RePORTER |
What this research studies
This research investigates the role of lipid droplets in microglial cells, which are crucial for brain health, particularly in the context of Alzheimer's disease (AD). By studying mouse models, the research aims to understand how changes in lipid metabolism in these immune cells influence their function and the progression of AD. The approach involves examining how microglia transition between different states in response to amyloid beta accumulation and tau protein aggregation, which are hallmarks of AD. The findings could provide insights into new therapeutic strategies targeting microglial activity to slow down or modify the disease course.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for Alzheimer's disease or those in the early stages of the condition.
Not a fit: Patients with advanced Alzheimer's disease or those without any genetic predisposition to the condition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that modify the progression of Alzheimer's disease, potentially improving outcomes for patients.
How similar studies have performed: While the specific approach of targeting microglial lipid metabolism is novel, similar studies have shown promise in understanding microglial roles in neurodegeneration.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Tabor, George Travis — Washington University
- Study coordinator: Tabor, George Travis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.